NSE
LALPATHLAB

Dr. Lal Path Labs Ltd.

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Dr. Lal Path Labs Ltd. Stock Price

Vitals

Today's Low:
₹2182
Today's High:
₹2238.45
Open Price:
₹2201.05
52W Low:
₹1758.2268
52W High:
₹2745.1659
Prev. Close:
₹2219.3501
Volume:
2702

Company Statistics

Market Cap.:
₹181.79 billion
Book Value:
201.014
Revenue TTM:
₹20.55 billion
Operating Margin TTM:
17.96%
Gross Profit TTM:
₹7.58 billion
Profit Margin:
12.84%
Return on Assets TTM:
8.96%
Return on Equity TTM:
14.87%

Company Profile

Dr. Lal Path Labs Ltd. had its IPO on under the ticker symbol LALPATHLAB.

The company operates in the Healthcare sector and Diagnostics & Research industry. Dr. Lal Path Labs Ltd. has a staff strength of 4,048 employees.

Stock update

Shares of Dr. Lal Path Labs Ltd. opened at ₹2201.05 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹2182 - ₹2238.45, and closed at ₹2205.4.

This is a -0.63% slip from the previous day's closing price.

A total volume of 2,702 shares were traded at the close of the day’s session.

In the last one week, shares of Dr. Lal Path Labs Ltd. have increased by +1.62%.

Dr. Lal Path Labs Ltd.'s Key Ratios

Dr. Lal Path Labs Ltd. has a market cap of ₹181.79 billion, indicating a price to book ratio of 12.7034 and a price to sales ratio of 9.7764.

In the last 12-months Dr. Lal Path Labs Ltd.’s revenue was ₹20.55 billion with a gross profit of ₹7.58 billion and an EBITDA of ₹5.41 billion. The EBITDA ratio measures Dr. Lal Path Labs Ltd.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Dr. Lal Path Labs Ltd.’s operating margin was 17.96% while its return on assets stood at 8.96% with a return of equity of 14.87%.

In Q2, Dr. Lal Path Labs Ltd.’s quarterly earnings growth was a positive 42.7% while revenue growth was a positive 7.6%.

Dr. Lal Path Labs Ltd.’s PE and PEG Ratio

Forward PE
62.1118
Trailing PE
68.7932
PEG

Its diluted EPS in the last 12-months stands at ₹31.82 per share while it has a forward price to earnings multiple of 62.1118 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dr. Lal Path Labs Ltd.’s profitability.

Dr. Lal Path Labs Ltd. stock is trading at a EV to sales ratio of 9.6352 and a EV to EBITDA ratio of 36.5167. Its price to sales ratio in the trailing 12-months stood at 9.7764.

Dr. Lal Path Labs Ltd. stock pays annual dividends of ₹12 per share, indicating a yield of 0.81% and a payout ratio of 18.93%.

Balance sheet and cash flow metrics

Total Assets
₹23.86 billion
Total Liabilities
₹4.70 billion
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
18.93%

Dr. Lal Path Labs Ltd. ended 2024 with ₹23.86 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹23.86 billion while shareholder equity stood at ₹16.66 billion.

Dr. Lal Path Labs Ltd. ended 2024 with ₹0 in deferred long-term liabilities, ₹4.70 billion in other current liabilities, 833680000.00 in common stock, ₹15.83 billion in retained earnings and ₹5.48 billion in goodwill. Its cash balance stood at ₹2.64 billion and cash and short-term investments were ₹8.51 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹833.34 million.

Dr. Lal Path Labs Ltd.’s total current assets stands at ₹9.73 billion while long-term investments were ₹0 and short-term investments were ₹1.86 billion. Its net receivables were ₹708.24 million compared to accounts payable of ₹1.56 billion and inventory worth ₹338.06 million.

In 2024, Dr. Lal Path Labs Ltd.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Dr. Lal Path Labs Ltd. paid ₹0.19 in dividends in 2024.

Other key metrics

Current Trading Price
₹2205.4
52-Week High
₹2745.1659
52-Week Low
₹1758.2268
Analyst Target Price

Dr. Lal Path Labs Ltd. stock is currently trading at ₹2205.4 per share. It touched a 52-week high of ₹2745.1659 and a 52-week low of ₹2745.1659. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹2291.64 and 200-day moving average was ₹2115.62 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5725.7% of the company’s stock are held by insiders while 2384.7% are held by institutions.

Frequently Asked Questions About Dr. Lal Path Labs Ltd.

The stock symbol (also called stock or share ticker) of Dr. Lal Path Labs Ltd. is LALPATHLAB

The IPO of Dr. Lal Path Labs Ltd. took place on

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
₹16.06
0.17
+1.07%
₹4.67
0.17
+3.78%
₹7.47
-0.74
-9.01%
₹88.01
-1.08
-1.21%
₹365.05
-6.15
-1.66%
₹412.3
-1.7
-0.41%
₹15.7
-0.54
-3.33%
₹172.2
3.35
+1.98%
₹15.98
1.96
+13.97%
₹0.1
-0
-4.49%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Address